Effect of low molecular weight dextran on acrocyanosis and scleroderma.
D000328:Adult; D001799:Blood Sedimentation; D001831:Body Temperature / Q000187:drug effects; D003490:Cyanosis / Q000097:blood / Q000188:drug therapy*; D003911:Dextrans / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D005385:Fingers / Q000098:blood supply; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D010992:Plethysmography, Impedance; D012039:Regional Blood Flow / Q000187:drug effects; D012595:Scleroderma, Systemic / Q000097:blood / Q000188:drug therapy*; D012879:Skin Physiological Phenomena; D014680:Veins / Q000502:physiology
D003911:Dextrans; D005340:Fibrinogen